Thus, this model may represent an invaluable new tool to facilitate the analysis of TGFβ1-driven fibrogenic mechanisms and advance pre-clinical biomarker and drug discovery for IPF. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.